Structure of hepatic microbodies in rats treated with acetylsalicylic acid, clofibrate, and dimethrin.
D000818:Animals; D001241:Aspirin / Q000009:adverse effects*; D001593:Benzyl Compounds / Q000009:adverse effects; D001835:Body Weight / Q000187:drug effects; D002264:Carboxylic Acids / Q000009:adverse effects; D002784:Cholesterol / Q000097:blood; D011723:Chrysanthemum cinerariifolium; D002994:Clofibrate / Q000009:adverse effects*; D003521:Cyclopropanes / Q000009:adverse effects*; D004721:Endoplasmic Reticulum / Q000473:pathology; D006529:Hepatomegaly / Q000139:chemically induced; D006651:Histocytochemistry; D008099:Liver / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008830:Microbodies / Q000187:drug effects; D009929:Organ Size; D009940:Organoids / Q000187:drug effects*; D051381:Rats; D014280:Triglycerides / Q000097:blood
D001593:Benzyl Compounds; D002264:Carboxylic Acids; D003521:Cyclopropanes; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate; D001241:Aspirin